A lot of competition in the needle-free market. But this isn't about needle-free technology, it's about being able to measure depth of patient skin/fat so as to get the drug into the right depth. Maybe that has a market somewhere. No idea. The company has been a shocker since 2004.
- Forums
- ASX - By Stock
- NAL
- contract deal...will set it 40c
contract deal...will set it 40c, page-3
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)